Maryland HB1377 establishes a Prescription Drug Repository Program to manage and redistribute safe prescription drugs.

Maryland HB1377 creates a Prescription Drug Repository Program overseen by the Secretary of Health. This program collaborates with the federal Drug Enforcement Agency and four state repositories to manage and redistribute safe prescription drugs. The program aims to expand medication access for underserved populations, reduce pharmaceutical waste, and ensure drug safety. Repositories must package collected medications according to specific requirements and transfer them to designated drop-off sites. The program will be in effect until December 31, 2027, after which it will be abrogated.

Maryland HB1377 establishes a Prescription Drug Repository Program to manage and redistribute safe prescription drugs.

Maryland HB1377 creates a Prescription Drug Repository Program overseen by the Secretary of Health. This program collaborates with the federal Drug Enforcement Agency and four state repositories to manage and redistribute safe prescription drugs. The program aims to expand medication access for underserved populations, reduce pharmaceutical waste, and ensure drug safety. Repositories must package collected medications according to specific requirements and transfer them to designated drop-off sites. The program will be in effect until December 31, 2027, after which it will be abrogated.